Genetic Engineering & Biotechnology News

NOV1 2018

Genetic Engineering & Biotechnology News (GEN) is the world's most widely read biotech publication. It provides the R&D community with critical information on the tools, technologies, and trends that drive the biotech industry.

Issue link: https://gen.epubxp.com/i/1042256

Contents of this Issue

Navigation

Page 34 of 57

For more information, visit our website (GENengnews.com), click on New Products, and search through our comprehensive new products database. New Products GENengnews.com | Genetic Engineering & Biotechnology News | NOVEMBER 1, 2018 | 33 People Abcam. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29 Advanced Analytical . . . . . . . . . . . . . . . . . 10 BioSpec . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33 c-LEcta . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29 BMG Labtech . . . . . . . . . . . . . . . . . . . . . . . . 11 Cell Applications . . . . . . . . . . . . . . . . . . . . 20 Clinical OMICs . . . . . . . . . . . . . . . . . . . . . . . 33 CRISPR Journal . . . . . . . . . . . . . . . . . . . . . . . 28 GEN/BD webinar . . . . . . . . . . . . . . . . . . . . . 12 GEN/Waters webinar . . . . . . . . . . . . . . . . . 24 Human Gene Therapy . . . . . . . . . . . . . . . . 21 Integra Biosciences . . . . . . . . . . . . . . . . . . 11 Merck . . . . . . . . . . . . . . . . . . . . . . . . . 18 -19,35 MilliporeSigma . . . . . . . . . . . . . . . 18 -19,35 Nova Biomedical . . . . . . . . . . . . . . . . . . . . . . 9 Novasep Process . . . . . . . . . . . . . . . . . . . . 21 OMICS: Journal . . . . . . . . . . . . . . . . . . . . . . 15 PerkinElmer . . . . . . . . . . . . . . . . . . . . . . . . . . . 7 Promega . . . . . . . . . . . . . . . . . . . 13,15,17, 36 Quanterix . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2 Rockland Immunochemicals . . . . . . . . . 17 Sonntek . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33 Terumo BCT . . . . . . . . . . . . . . . . . . . . . . . . . 23 Thermo Fisher Scientific . . . . . . . . . . . 5, 27 A P P L I C AT I O N N O T E c-LEcta . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 25 Advertiser Index MACROPHAGE PHARMA established a scientific advisory board consisting of: Tanja de Gruijl, Ph.D., Liza Makowski, Ph.D., Alberto Mantovani, M.D., Luke O'Neill, Ph.D., Mike Owen, Ph.D., and Laszlo Radvanyi, Ph.D. HALOZYME hired Benjamin Hickey as chief commercial officer, and appointed Bernadette Connaughton to its board of directors. ACTINIUM PHARMACEUTICALS welcomed Robert N. Daly, Ph.D., as vice president, head of clinical operations. Anne White is the new senior vice president of LILLY, and president of LILLY ONCOLOGY. AMICUS THERAPEUTICS elected Lynn D. Bleil to its board of directors. GEOVAX hired Mary Hauser, Ph.D., as scientist, and Mugdha Vasireddi, Ph.D., as immunologist. CARSGEN THERAPEUTICS added Hong Ma, M.D., as senior vice president, clinical development. PAVELLA THERAPEUTICS appointed Elain Heron, Ph.D., to its board of directors. XW LABORATORIES wel- comed Daniel Canafax, PharmD., as CMO. ONCOSEC added Alain Algazi, M.D., as clinical strategic advisor. GOSSAMER BIO welcomed Luisa Salter-Cid, Ph.D., as CSO. TEMPEST THERAPEUTICS added Ginna Laport, M.D., as CMO. John Hunter, Ph.D., joined SITEONE THERAPEUTICS as CSO. ALACRITA added Peter G. Traber, M.D., as partner. PIVOT PHARMACEUTICALS elected Joseph Borovsky, Ph.D., as chairman of its board of directors. Linda Basse, M.D., Ph.D., is the new CMO at MEDIVIR. DEFINIGEN appointed Sir John Savill, MB ChB, Ph.D., to its board of directors. Scott Smith is the new president of BIOALTA. OWLSTONE MEDICAL appointed Andy Richards, Ph.D., to its board of directors. Dr. Richards was the founder and executive director of Chiroscience (merged with Celltech in 1999). Since, then he has been involved in the development of more than 25 ventures, including Cambridge Biotechnology and Arakis. Profile CODIAK BIOSCIENCES welcomed Robert M. Brenner, M.D., as executive vice presi- dent, head of R&D. Dr. Brenner was evp and CMO at Orionis Biosciences. Prior to that, he was president and CEO of AlloCure. Dr. Brenner began his career at Amgen. Profile James Kupiec, M.D., joined PROMIS NEUROSCIENCES as CMO. Dr. Kupiec is a former vice president at Pfizer. Prior to that, he worked at Sanofi- Synthelabo. And earlier in his career, he worked at Ciba- Geigy Pharmaceuticals. Profile Clinical OMICs extends GEN's comprehensive coverage to the clinic by focusing on the application of revolutionary molecular technologies in medical practice. Topics covered include personalized and precision medicine, next-gen sequencing, bioinformatics, reimbursement, and bioethics. To see past issues, recent news, and subscribe, go to: clinicalomics.com GEN'S ePUB Molecular Diagnostics in Personalized Medicine Reprints Karen Ballen 914-740-2194 reprints@GENengnews.com GEN offers reprints of individual articles — in print- ed or electronic form — to increase awareness of your product or company. Order today! Subscribe Send your People Announcements to people@GENengnews.com Classified

Articles in this issue

Links on this page

Archives of this issue

view archives of Genetic Engineering & Biotechnology News - NOV1 2018